IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population

Vγ9Vδ2 T cells contribute to the immune response against many tumor types through their direct cytotoxic activity and capacity to regulate the biological functions of other immune cells, such as dendritic cells and IFN-γ-producing CD8+ T cells. However, their presence in the tumor microenvironment h...

Full description

Bibliographic Details
Main Authors: Clément Barjon, Henri-Alexandre Michaud, Angeline Fages, Cécile Dejou, Alexandre Zampieri, Laetitia They, Aurélie Gennetier, Françoise Sanchez, Laurent Gros, Jean-François Eliaou, Nathalie Bonnefoy, Virginie Lafont
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1379642
id doaj-558638ed3e754130a8d2e0ec44e88c32
record_format Article
spelling doaj-558638ed3e754130a8d2e0ec44e88c322020-11-25T03:43:47ZengTaylor & Francis GroupOncoImmunology2162-402X2018-01-017110.1080/2162402X.2017.13796421379642IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory populationClément Barjon0Henri-Alexandre Michaud1Angeline Fages2Cécile Dejou3Alexandre Zampieri4Laetitia They5Aurélie Gennetier6Françoise Sanchez7Laurent Gros8Jean-François Eliaou9Nathalie Bonnefoy10Virginie Lafont11Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)OREGA BiotechInstitut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Institut de Recherche en Cancérologie de Montpellier (IRCM); INSERM, U1194; Université Montpellier; Institut Régional du Cancer de Montpellier (ICM)Vγ9Vδ2 T cells contribute to the immune response against many tumor types through their direct cytotoxic activity and capacity to regulate the biological functions of other immune cells, such as dendritic cells and IFN-γ-producing CD8+ T cells. However, their presence in the tumor microenvironment has also been associated with poor prognosis in breast, colon and pancreatic cancers. Additionally, recent studies demonstrated that cytokines can confer some plasticity to Vγ9Vδ2 T cells and promote their differentiation into cells with regulatory functions. Here, we demonstrated that activation of Vγ9Vδ2 T cells isolated from healthy donors and cultured in the presence of IL-21 favors the emergence of a subpopulation of Vγ9Vδ2 T cells that express the ectonucleotidase CD73 and inhibits T cell proliferation in a CD73/adenosine-dependent manner. This subpopulation produces IL-10 and IL-8 and displays lower effector functions and cytotoxic activity than CD73-negative Vγ9Vδ2 T cells. We also showed, in a syngeneic mouse tumor model, the existence of a tumor-infiltrating γδ T cell subpopulation that produces IL-10 and strongly expresses CD73. Moreover, maturation, IL-12 production and induction of antigen-specific T cell proliferation are impaired in DC co-cultured with IL-21-amplified Vγ9Vδ2 T cells. Altogether, these data indicate that IL-21 promotes Vγ9Vδ2 T cell regulatory functions by favoring the development of an immunosuppressive CD73+ subpopulation. Thus, when present in the tumor microenvironment, IL-21 might negatively impact γδ T cell anti-tumor functions.http://dx.doi.org/10.1080/2162402X.2017.1379642γδ t cellscd73il-10il-21adenosineregulatory functionstumor microenvironment
collection DOAJ
language English
format Article
sources DOAJ
author Clément Barjon
Henri-Alexandre Michaud
Angeline Fages
Cécile Dejou
Alexandre Zampieri
Laetitia They
Aurélie Gennetier
Françoise Sanchez
Laurent Gros
Jean-François Eliaou
Nathalie Bonnefoy
Virginie Lafont
spellingShingle Clément Barjon
Henri-Alexandre Michaud
Angeline Fages
Cécile Dejou
Alexandre Zampieri
Laetitia They
Aurélie Gennetier
Françoise Sanchez
Laurent Gros
Jean-François Eliaou
Nathalie Bonnefoy
Virginie Lafont
IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
OncoImmunology
γδ t cells
cd73
il-10
il-21
adenosine
regulatory functions
tumor microenvironment
author_facet Clément Barjon
Henri-Alexandre Michaud
Angeline Fages
Cécile Dejou
Alexandre Zampieri
Laetitia They
Aurélie Gennetier
Françoise Sanchez
Laurent Gros
Jean-François Eliaou
Nathalie Bonnefoy
Virginie Lafont
author_sort Clément Barjon
title IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
title_short IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
title_full IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
title_fullStr IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
title_full_unstemmed IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory population
title_sort il-21 promotes the development of a cd73-positive vγ9vδ2 t cell regulatory population
publisher Taylor & Francis Group
series OncoImmunology
issn 2162-402X
publishDate 2018-01-01
description Vγ9Vδ2 T cells contribute to the immune response against many tumor types through their direct cytotoxic activity and capacity to regulate the biological functions of other immune cells, such as dendritic cells and IFN-γ-producing CD8+ T cells. However, their presence in the tumor microenvironment has also been associated with poor prognosis in breast, colon and pancreatic cancers. Additionally, recent studies demonstrated that cytokines can confer some plasticity to Vγ9Vδ2 T cells and promote their differentiation into cells with regulatory functions. Here, we demonstrated that activation of Vγ9Vδ2 T cells isolated from healthy donors and cultured in the presence of IL-21 favors the emergence of a subpopulation of Vγ9Vδ2 T cells that express the ectonucleotidase CD73 and inhibits T cell proliferation in a CD73/adenosine-dependent manner. This subpopulation produces IL-10 and IL-8 and displays lower effector functions and cytotoxic activity than CD73-negative Vγ9Vδ2 T cells. We also showed, in a syngeneic mouse tumor model, the existence of a tumor-infiltrating γδ T cell subpopulation that produces IL-10 and strongly expresses CD73. Moreover, maturation, IL-12 production and induction of antigen-specific T cell proliferation are impaired in DC co-cultured with IL-21-amplified Vγ9Vδ2 T cells. Altogether, these data indicate that IL-21 promotes Vγ9Vδ2 T cell regulatory functions by favoring the development of an immunosuppressive CD73+ subpopulation. Thus, when present in the tumor microenvironment, IL-21 might negatively impact γδ T cell anti-tumor functions.
topic γδ t cells
cd73
il-10
il-21
adenosine
regulatory functions
tumor microenvironment
url http://dx.doi.org/10.1080/2162402X.2017.1379642
work_keys_str_mv AT clementbarjon il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT henrialexandremichaud il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT angelinefages il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT ceciledejou il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT alexandrezampieri il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT laetitiathey il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT aureliegennetier il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT francoisesanchez il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT laurentgros il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT jeanfrancoiseliaou il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT nathaliebonnefoy il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
AT virginielafont il21promotesthedevelopmentofacd73positivevg9vd2tcellregulatorypopulation
_version_ 1724518402348810240